Medinex Limited (SGX:OTX)
Singapore · Delayed Price · Currency is SGD 0.2300
+0.0050 (2.22%)
At close: Jul 24, 2026
Medinex Income Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 12.41 | 12.81 | 12.58 | 12.97 | 11.99 |
Other Revenue | - | 0 | 0 | 0 | 0.05 |
| 12.41 | 12.82 | 12.59 | 12.97 | 12.04 | |
Revenue Growth (YoY) | -3.14% | 1.82% | -2.94% | 7.69% | 11.65% |
Cost of Revenue | 7.73 | 8.09 | 8.25 | 8.75 | 7.92 |
Gross Profit | 4.68 | 4.73 | 4.33 | 4.22 | 4.13 |
Other Operating Expenses | 1.25 | 1.21 | 3.15 | 2.13 | 0.83 |
Operating Expenses | 1.79 | 1.74 | 3.83 | 2.78 | 1.71 |
Operating Income | 2.89 | 2.99 | 0.5 | 1.44 | 2.41 |
Interest Expense | -0.04 | -0.05 | -0.06 | -0.07 | -0.09 |
Interest & Investment Income | 0.22 | 0.2 | 0.33 | 0.34 | 0.36 |
Earnings From Equity Investments | 0.14 | 0.07 | 0.17 | 0.08 | -0 |
Other Non Operating Income (Expenses) | 0.01 | 0.01 | 0.07 | 0.25 | 0.02 |
EBT Excluding Unusual Items | 3.22 | 3.22 | 1.02 | 2.04 | 2.7 |
Impairment of Goodwill | -1.6 | -0.26 | - | - | -0.34 |
Gain (Loss) on Sale of Investments | 0.77 | 0.01 | - | - | 0.82 |
Gain (Loss) on Sale of Assets | 0.02 | 0.01 | - | - | - |
Other Unusual Items | 0 | - | - | - | 0.08 |
Pretax Income | 2.42 | 2.98 | 1.02 | 2.04 | 3.27 |
Income Tax Expense | 0.2 | 0.15 | 0.15 | 0.35 | 0.37 |
Earnings From Continuing Operations | 2.23 | 2.83 | 0.87 | 1.69 | 2.9 |
Minority Interest in Earnings | -0 | 0 | 0.17 | 0.01 | -0.09 |
Net Income | 2.22 | 2.83 | 1.03 | 1.7 | 2.81 |
Net Income to Common | 2.22 | 2.83 | 1.03 | 1.7 | 2.81 |
Net Income Growth | -21.53% | 174.35% | -39.23% | -39.43% | -19.65% |
Shares Outstanding (Basic) | 133 | 132 | 132 | 132 | 131 |
Shares Outstanding (Diluted) | 133 | 135 | 135 | 135 | 133 |
Shares Change (YoY) | -1.23% | - | - | 1.68% | 1.13% |
EPS (Basic) | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
EPS (Diluted) | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
EPS Growth | -20.51% | 172.71% | -38.88% | -40.57% | -20.38% |
Free Cash Flow | 2.55 | 3.33 | 2.67 | 2.83 | 2.65 |
Free Cash Flow Per Share | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
Dividend Per Share | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 37.72% | 36.90% | 34.42% | 32.53% | 34.27% |
Operating Margin | 23.28% | 23.34% | 3.99% | 11.10% | 20.03% |
Profit Margin | 17.92% | 22.12% | 8.21% | 13.11% | 23.31% |
Free Cash Flow Margin | 20.54% | 25.95% | 21.18% | 21.86% | 22.02% |
EBITDA | 3.01 | 3.15 | 0.77 | 1.7 | 2.57 |
EBITDA Margin | 24.21% | 24.59% | 6.12% | 13.14% | 21.38% |
D&A For EBITDA | 0.12 | 0.16 | 0.27 | 0.26 | 0.16 |
EBIT | 2.89 | 2.99 | 0.5 | 1.44 | 2.41 |
EBIT Margin | 23.28% | 23.34% | 3.99% | 11.10% | 20.03% |
Effective Tax Rate | 8.07% | 5.05% | 14.66% | 17.32% | 11.34% |